#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mucous membrane pemphigoid Hypersensitivity pneumonitis Gastrointestinal disorder Hypophosphatasia Neuroendocrine cell hyperplasia of infancy Endometrial cancer recurrent Hyperoxaluria Neurodermatitis Severe myoclonic epilepsy of infancy Stress cardiomyopathy Staphylococcal infection X-linked lymphoproliferative syndrome Plasma cell myeloma Mantle cell lymphoma refractory Leiomyosarcoma metastatic More trials…

    Learn about Rare Diseases

    Glycogen storage disease type I – Life with Disease Hairy cell leukaemia recurrent – Life with Disease Familial amyotrophic lateral sclerosis – Life with Disease Kearns-Sayre syndrome – Trials in Disease Ocular melanoma – Treatment Alternating hemiplegia of childhood – Diagnostics Pituitary-dependent Cushing’s syndrome – Basic Information Retinitis pigmentosa Atypical haemolytic uraemic syndrome – Basic Information Alport’s syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cldn6 Car-T(A) AMO959 PRT3789 Mr0005 Pehero Onfekafusp Alfa Lutropin Alfa YOHIMBINE HYDROCHLORIDE Levocabastine Hydrochloride LYSERGIDE Amoxicillin Vitamin A Bp GVV858 Bulevirtide IHMA-2121771-1 Carboplatin ANOC-001 IDP-121 INDAPAMIDE HEMIHYDRATE MRNA-1345 More therapies…

    Learn about Your Condition

    Schizoaffective disorder Barrett's oesophagus Small intestine leiomyosarcoma Papulopustular rosacea Hypercholesterolaemia Biliary neoplasm Medulloblastoma recurrent Iron deficiency anaemia Epstein-Barr virus infection Premature baby Viral myocarditis Breast cancer Juvenile absence epilepsy Exudative retinopathy Mantle cell lymphoma stage II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mental Disorders

  • Safe Discontinuation of Antidepressants in Patients with Remitted Depression: Amitriptyline, Fluoxetine, Paroxetine, and Drug Combination Study

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Depression
    Investigated Drugs:
    • Citalopram Hydrochloride
    • Escitalopram Oxalate
    • Paroxetine
    Italy

  • Study on the Effectiveness and Safety of Ademetionine with Antidepressants for Patients with Major Depressive Disorder

    Recruiting

    3 1 1
    Investigated Drugs:
    • Ademetionine
    Italy

  • Study on Vafidemstat for Treating Negative Symptoms and Cognitive Impairment in Adults with Schizophrenia

    Recruiting

    2 1
    Investigated Drugs:
    • Vafidemstat
    Bulgaria Poland Romania Slovakia Spain

  • Study of Ambroxol Treatment in People with Early Stage or Mild Lewy Body Dementia

    Recruiting

    2 1
    Investigated Diseases:
    • Dementia with Lewy bodies
    Investigated Drugs:
    • Ambroxol Hydrochloride
    Norway

  • Study on Rituximab for Patients with Mental Disorders and Autoimmunity

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Mental disorder
    Investigated Drugs:
    • Rituximab
    France

  • Study of diazepam and oxazepam in patients with benzodiazepine and opioid dependence who are receiving opioid agonist therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Drug dependence
    Investigated Drugs:
    • Oxazepam
    • Diazepam
    Norway
Previous Page
1 … 17 18 19 20 21 … 40
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!